Evidence map›Paper›PMID 36547920›Full record

ReviewMarine drugs2022

Francesco Margiotta, Laura Micheli, Clara Ciampi, Carla Ghelardini, J Michael McIntosh, Lorenzo Di Cesare Mannelli

Open access · goldAbstract readReview
In one paragraph

Review in Marine drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Francesco MargiottaDepartment of Neuroscience, Psychology, Drug Research and Child Health-NEUROFARBA, Pharmacology and Toxicology Section, University of Florence, 50139 Florence, Italy.ORCID 0000-0002-4172-2478
Laura MicheliDepartment of Neuroscience, Psychology, Drug Research and Child Health-NEUROFARBA, Pharmacology and Toxicology Section, University of Florence, 50139 Florence, Italy.ORCID 0000-0001-8834-5801
Clara CiampiDepartment of Neuroscience, Psychology, Drug Research and Child Health-NEUROFARBA, Pharmacology and Toxicology Section, University of Florence, 50139 Florence, Italy.
Carla GhelardiniDepartment of Neuroscience, Psychology, Drug Research and Child Health-NEUROFARBA, Pharmacology and Toxicology Section, University of Florence, 50139 Florence, Italy.
J Michael McIntoshGeorge E. Wohlen Veterans Affairs Medical Center, Salt Lake City, UT 84148, USA.
Lorenzo Di Cesare MannelliDepartment of Neuroscience, Psychology, Drug Research and Child Health-NEUROFARBA, Pharmacology and Toxicology Section, University of Florence, 50139 Florence, Italy.ORCID 0000-0001-8374-4432
University of Florence · ITUniversity of Utah · US

Funding

Development and Application of Nicotinic Acetylcholine Receptor Targeted Peptides for Biomedical ResearchR35GM136430 · NIGMS · UNIVERSITY OF UTAH · PI MCINTOSH, J MICHAEL · 2020 to 2024
$2.3M
NIGMS NIH HHS R35 GM136430NIH HHS R35 GM136430
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ConotoxinsConus SnailReceptors, NicotinicAnimalsAquatic OrganismsNicotinic AntagonistsPeptidesConotoxinsNicotinic AntagonistsPeptidesReceptors, Nicotinicalpha9alpha10 nAChRsalpha-conotoxinsM-conotoxinsnAChRsneuropathic painpainRegIIARgIARgIA analoguesRgIB

Identifiers

PMID36547920
PMCPMC9783627
OpenAlexW4311154297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.